BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in BridgeBio Pharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- +27 vs. Q2 2023
- Shares held
- 161.1M
- +14.0M (+9.5%) vs. Q2 2023
- Total value
- $4.24B
- +$1.71B (+67.7%) vs. Q2 2023
- New holders
- 54
- 66 more added
- Sold out
- 27
- 75 more reduced
3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 475 | $14.4B |
| Q1 2026 | 462 | $14.4B |
| Q4 2025 | 435 | $14.4B |
| Q3 2025 | 392 | $9.62B |
| Q2 2025 | 359 | $8.15B |
| Q1 2025 | 304 | $6.45B |
| Q4 2024 | 263 | $4.85B |
| Q3 2024 | 254 | $4.39B |
| Q2 2024 | 251 | $4.43B |
| Q1 2024 | 244 | $5.31B |
| Q4 2023 | 247 | $6.69B |
| Q3 2023 | 221 | $4.24B |
| Q2 2023 | 197 | $2.58B |
| Q1 2023 | 213 | $2.53B |
| Q4 2022 | 179 | $1.10B |
| Q3 2022 | 181 | $1.44B |
| Q2 2022 | 165 | $1.28B |
| Q1 2022 | 179 | $1.45B |
| Q4 2021 | 195 | $2.37B |
| Q3 2021 | 212 | $6.56B |
| Q2 2021 | 201 | $8.70B |
| Q1 2021 | 199 | $8.69B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 1,341,243 | $35.4M | 0.06% | −291,743−17.9% | Reduced |
| Wellington Management Group LLP | 1,419,550 | $37.4M | 0.01% | +1,419,550 | New |
| Goldman Sachs Group Inc | 1,425,157 | $37.6M | 0.01% | +399,689+39.0% | Added |
| Morgan Stanley | 1,448,060 | $38.2M | 0.00% | +894,647+161.7% | Added |
| Citigroup Inc | 1,587,592 | $41.9M | 0.06% | +160,076+11.2% | Added |
| Perceptive Advisors LLC | 1,748,933 | $46.1M | 1.55% | 00.0% | Unchanged |
| SC US (TTGP), Ltd. | 1,860,364 | $49.1M | 0.45% | 00.0% | Unchanged |
| FMR LLC | 2,427,522 | $61.0M | 0.01% | +766,639+46.2% | Added |
| Geode Capital Management, LLC | 2,511,180 | $66.2M | 0.01% | +91,810+3.8% | Added |
| Alliancebernstein L.P. | 2,716,140 | $71.6M | 0.03% | +2,560,549+1,645.7% | Added |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71.9M | 4.78% | +737,073+37.1% | Added |
| Pictet Asset Management Holding SA | 2,740,022 | $72.3M | 0.09% | +2,740,022 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,782,750 | $73.4M | 1.64% | −210,697−7.0% | Reduced |
| Cormorant Asset Management, LP | 4,662,530 | $123.0M | 7.17% | +493,351+11.8% | Added |
| State Street Corp | 5,040,414 | $132.9M | 0.01% | −2,028,946−28.7% | Reduced |
| Laurion Capital Management LP | 5,651,039 | $149.0M | 3.90% | +901,696+19.0% | Added |
| Aisling Capital Management LP | 6,068,125 | $160.0M | 65.94% | 00.0% | Unchanged |
| BlackRock Inc. | 9,249,943 | $243.9M | 0.01% | −331,786−3.5% | Reduced |
| Vanguard Group Inc | 11,275,981 | $297.3M | 0.01% | −409,016−3.5% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 25,120,991 | $662.4M | 2.69% | −1,500,000−5.6% | Reduced |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819.1M | 28.75% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −364,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −205,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −185,063−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −77,500−100.0% | Sold out |
| Vestcor Inc | 0 | $0 | 0.00% | −73,849−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −59,889−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −56,293−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −53,473−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −28,413−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −27,490−100.0% | Sold out |
| Wilbanks Smith & Thomas Asset Management LLC | 0 | $0 | 0.00% | −23,641−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −20,311−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,248−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −17,291−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −16,870−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −12,703−100.0% | Sold out |
| Hunting Hill Global Capital, LLC | 0 | $0 | 0.00% | −10,387−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −7,152−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −6,324−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −678−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −460−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −365−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |
| Coastal Capital Group, Inc. | – | – | – | – | Not filed |